Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 6553 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–22–21GY] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Performance 

Monitoring of CDC’s Comprehensive 

Suicide Prevention Program to the 

Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on August 6, 2021 to obtain 

comments from the public and affected 

agencies. CDC did not receive comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Performance Monitoring of CDC’s 

Comprehensive Suicide Prevention 

Program—New—National Center for 

Injury Prevention and Control (NCIPC), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC) seeks OMB approval 

to collect information from recipients 

funded under the Comprehensive 

Suicide Prevention Program cooperative 

agreement (CE20–2001), hereafter 

known as CSP. OMB approval is 

requested for three years of the five-year 

funding period. The electronic 

collection of information for program 

and performance monitoring aligns with 

three of CDC’s Data Modernization 

Initiative Key Objectives to: 

• Develop and implement cloudbased approaches for automating data 

collection and supporting multidirectional data flows among STLT 

partners and CDC. 

• Reduce burden for data providers 

and public health agencies. 

• Ensure systems and services are 

scalable, interoperable, and adaptable to 

meet evolving needs. 

Recipients will report progress and 

activity information to CDC on an 

annual schedule using a web-based 

Partners’ Portal. The Partners’ Portal 

allows recipients to fulfill their annual 

reporting obligations efficiently by 

employing user-friendly, easily 

accessible web-based instruments to 

collect necessary information for both 

progress reports and continuation 

applications including work plans. This 

approach enables recipients to save 

pertinent information from one 

reporting period to the next and reduces 

the administrative burden on the annual 

continuation application and the 

performance monitoring process. 

Awardee program staff can review the 

completeness of data needed to generate 

required reports, enter basic summary 

data for reports annually, and finalize 

and save required reports for upload 

into other reporting systems as required. 

Information to be collected will 

provide crucial data for program 

performance monitoring and provide 

CDC with the capacity to respond in a 

timely manner to requests for 

information about the program from the 

Department of Health and Human 

Services (HHS), the White House, 

Congress, and other sources. 

Information to be collected will also 

strengthen CDC’s ability to monitor 

awardee progress, provide data-driven 

technical assistance, and disseminate 

the most current surveillance data on 

suicide and suicide attempts. 

CDC requests OMB approval for an 

estimated 132 annual burden hours. 

There are no costs to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

CSP Program Recipients ................................ Annual Progress Report ................................. 11 1 12 


lotter on DSK11XQN23PROD with NOTICES1
6554 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–02399 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–20MR; Docket No. CDC–2022– 

0018] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Leptospirosis and Melioidosis 

Active Hospital-based Surveillance in 

Puerto Rico. The project aims to identify 

leptospirosis and melioidosis cases in 

Puerto Rico by establishing active 

surveillance for both diseases at four 

hospital sites for disease identification 

and treatment and to improve 

understanding of leptospirosis and 

melioidosis epidemiology and ecology 

in Puerto Rico for public health control 

and prevention planning. 

DATES: CDC must receive written 

comments on or before April 5, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0018 by either of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Leptospirosis and Melioidosis Active 

Hospital-based Surveillance in Puerto 

Rico—Existing Collection in Use 

Without an OMB Control Number— 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

This project aims to identify 

leptospirosis and melioidosis cases in 

Puerto Rico by establishing active 

surveillance for both diseases at four 

hospital sites for timely disease 

identification and treatment and to 

improve understanding of leptospirosis 

and melioidosis epidemiology and 

ecology in Puerto Rico for public health 

control and prevention planning. Both 

diseases can cause outbreaks after 

hurricanes and flooding, especially in 

tropical areas, and this project is being 

conducted in response to an increase in 

leptospirosis cases after Hurricanes Irma 

and Maria in 2017. 

Participants will be recruited from the 

population presenting to the emergency 

department of the four hospital sites 

with febrile illness, and will be 

interviewed to gather information on 

symptoms, possible exposures, and 

medical history, in addition to having 

diagnostic samples collected to test for 

leptospirosis plus or minus melioidosis 

(depending on presenting symptoms). 

Participants will also be interviewed 

approximately two weeks after 

enrollment to determine illness 

progression and outcome. Patients 

testing positive for leptospirosis, if 

willing, may have animal samples taken 

from their home or work environments 

to help determine the animal reservoirs 

related to human leptospirosis illness in 

Puerto Rico. 

CDC requests OMB approval for an 

estimated 1,675 annual burden hours. 

There is no cost to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Patient ............................. PIFA (screening) ................................ Up to 7,000 .................... 1 5/60 583 


lotter on DSK11XQN23PROD with NOTICES1